Abstracts
Résumé
L’observance des patientes avec une ostéoporose post-ménopausique diminue fortement après six mois de traitement. Cependant, en faisant le choix de poursuivre le traitement, elles sont souvent partagées entre la nécessité de le prendre et leurs préoccupations. Ces perceptions toutefois peuvent varier selon le type de traitement (per os, injection et supplémentation). Ainsi, 15 entretiens semi-structurés ont été réalisés auprès de patientes avec une ostéoporose post-ménopausique, dont l’analyse thématique a révélé que les patientes per os percevaient davantage la nécessité du traitement, alors que les groupes injection et supplémentation étaient plus préoccupés, même si leurs préoccupations divergent. Les professionnels de santé doivent par conséquent s’assurer de l’influence de leur prescription sur les perceptions des patientes.
Mots-clés :
- Ostéoporose post-ménopausique,
- traitement,
- perceptions,
- nécessité-préoccupation,
- approche qualitative
Abstract
Observance of patients with postmenopausal osteoporosis decreases significantly after six months of treatment. However, when choosing to continue treatment, they are often torn between the need to take it and their concerns. These perceptions, however, may vary according to the type of treatment (per os, injection and supplementation). For example, 15 semi-structured interviews were conducted with postmenopausal osteoporosis patients, and thematic analysis revealed that the per os patients perceived the need for treatment more, while the injection and supplementation groups were more concerned, although their concerns differed. Health professionals should therefore ensure that their prescribing influences patients' perceptions.
Keywords:
- postmenopausal osteoporosis,
- treatment,
- perceptions,
- necessity-concern,
- qualitative approach
Appendices
Bibliographie
- Aikens, J. E., Nease, D. E., Nau, D. P., Klinkman, M. S., & Schwenk, T. L. (2005). Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. The Annals of Family Medicine, 3(1), 23−30. https://doi.org/10.1370/afm.238
- Alami, S., Hervouet, L., Poiraudeau, S., Briot, K., & Roux, C. (2016). Barriers to effective postmenopausal osteoporosis treatment: A qualitative study of patients’ and practitioners’ views. PloS One, 11(6), e0158365. https://doi.org/10.1371/journal.pone.0158365
- Al Zadjali, F., Brooks, J., O’Neill, T. W., & Stanmore, E. (2023). Experiences of postmenopausal osteoporosis: A narrative review. Disability and Rehabilitation, 46(5), 1−13. https://doi.org/10.1080/09638288.2023.2169770
- Balcou-Debussche, M. (2010). Une approche ethnosociologique de l'éducation thérapeutique du patient dans le diabète de type 2. Dans J. Foucaud, J. Bury, M. Balcou-Debussche, & C. Eymard (Éds.), Éducation thérapeutique du patient : modèles, pratiques et évaluation. Savoirs en action. https://hal.univ-reunion.fr/hal-01226687
- Belgacem, A., Laouani Kechrid, C., Nouira, A., Ben Dhiab, M., Maatoug, J., Chelbi, S., & Soussi, S. (2022). Effectiveness of an osteoporosis prevention educational program in Tunisian premenopausal women working in sedentary occupations: A quasi-experimental study. Archives of Osteoporosis, 17(1), 1−9. https://doi.org/10.1007/s11657-022-01119-4
- Belgacem, A., Nouira, A., & Soussi, S. (2016). Perceptions of Tunisian women based on the health beliefs model and their practices related to osteoporosis. The Pan African Medical Journal, 23(42). https://doi.org/10.11604/pamj.2016.23.42.6643
- Bode, C., van der Heij, A., Taal, E., & van de Laar, M. A. (2010). Body-self unity and self-esteem in patients with rheumatic diseases. Psychology, Health & Medicine, 15(6), 672−684. https://doi.org/0.1080/13548506.2010.507774
- Brunner, R., Dunbar-Jacob, J., LeBoff, M. S., Granek, I., Bowen, D., Snetselaar, L. G., Shumaker, S. A., Ockene, J., Rosal, M., Wactawski-Wende, J., Cauley, J., Cochrane, B., Tinker, L., Jackson, R., Wang, C. Y., & Wu., L. (2009). Predictors of adherence in the women's health initiative calcium and vitamin D trial. Behavioral Medicine, 34(4), 145−155. https://doi.org/10.3200/BMED.34.4.145-155
- Cortet, B., & Bénichou, O. (2006). Adhérence, observance, persistance, concordance : prenons-nous en charge correctement nos patientes ostéoporotiques? Revue du rhumatisme, 73(9), e1−e9. https://doi.org/10.1016/j.rhum.2005.09.015
- Elaine, L., Papaioannou, A., Dolovich, L., Adachi, J., Sawka, A. M., Burns, S., Nair, K., & Pathak, A. (2008). Patients’ adherence to osteoporosis therapy: Exploring the perceptions of postmenopausal women. Canadian Family Physician, 54(3), 394−402. https://pubmed.ncbi.nlm.nih.gov/18337534/
- Fischbein, E. (1975). The intuitive sources of probabilistic thinking in children (Vol. 85). Springer Dordrecht. https://doi.org/10.1007/978-94-010-1858-6
- Foot, H., La Caze, A., Gujral, G., & Cottrell, N. (2016). The necessity–concerns framework predicts adherence to medication in multiple illness conditions: A meta-analysis. Patient Education and Counseling, 99(5), 706−717. https://doi.org/10.1016/j.pec.2015.11.004
- Granger, B. B., Ekman, I., Granger, C. B., Ostergren, J., Olofsson, B., Michelson, E., McMurray, John J. V., Yusuf, S., Pfeffer, M. A., & Swedberg, K. (2009). Adherence to medication according to sex and age in the CHARM programme. European Journal of Heart Failure, 11(11), 1092−1098. https://doi.org/10.1093/eurjhf/hfp142
- Horne, R. (1997). Representations of medication and treatment: Advances in theory and measurement. Dans K. J. Petrie & J. A. Weinman (Éds.), Perceptions of health and illness (p. 155–188). Psychology Press. https://doi.org/10.4324/9781315078908
- Horne, R. (2003). Treatment perceptions and self-regulation. Dans L. D. Cameron & H. Leventhal (Éds.), The self-regulation of health and illness behaviour (p. 138−153). Routledge. https://doi.org/10.4324/9780203553220
- Horne, R., Chapman, S. C., Parham, R., Freemantle, N., Forbes, A., & Cooper, V. (2013). Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: A meta-analytic review of the Necessity-Concerns Framework. PloS One, 8(12), e80633. https://doi.org/10.1371%2Fjournal.pone.0080633
- Horne, R., Cooper, V., Wileman, V., & Chan, A. (2019). Supporting adherence to medicines for long-term conditions: A perceptions and practicalities approach based on an extended common-sense model. European Psychologist, 24(1), 82−96. https://doi.org/10.1027/1016-9040/a000353
- Horne, R., Weinman, J., Barber, N., Elliott, R., Morgan, M., Cribb, A., & Kellar, I. (2005). Concordance, adherence and compliance in medicine taking. National Co-ordinating Centre for National Health Service Service Delivery and Organisation Research and Development. https://www.ahpo.net/assets/NCCSDO%20Compliance%202005.pdf
- Horne, R., Weinman, J., & Hankins, M. (1999). The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology and Health, 14(1), 1−24. https://doi.org/10.1080/08870449908407311
- Jerant, A., Chapman, B., Duberstein, P., Robbins, J., & Franks, P. (2011). Personality and medication non-adherence among older adults enrolled in a six-year trial. British Journal of Health Psychology, 16(1), 151−169. https://doi.org/10.1348/135910710X524219
- Kalichman, S. C., & Grebler, T. (2010). Stress and poverty predictors of treatment adherence among people with low-literacy living with HIV/AIDS. Psychosomatic Medicine, 72(8), 810−816. https://doi.org/10.1097/PSY.0b013e3181f01be3
- Kamatari, M., Koto, S., Ozawa, N., Urao, C., Suzuki, Y., Akasaka, E., Yanagimoto, K., & Sakota, K. (2007). Factors affecting long-term compliance of osteoporotic patients with bisphosphonate treatment and QOL assessment in actual practice: Alendronate and risedronate. Journal of Bone and Mineral Metabolism, 25(5), 302−309. https://doi.org/10.1007/s00774-007-0768-6
- Kendler, D. L., Macarios, D., Lillestol, M. J., Moffett, A., Satram-Hoang, S., Huang, J., Kaur, P., Tang, E. T., Wagman, R. B., & Horne, R. (2014). Influence of patient perceptions and preferences for osteoporosis medication on adherence behavior in the Denosumab Adherence Preference Satisfaction Study. Menopause, 21(1), 25−32. https://doi.org/10.1097/GME.0b013e31828f5e5d
- Lepage, L., & Lemétayer, F. (2024). Verbatims entretiens semi-structurés nécessité-préoccupation. https://doi.org/10.17605/OSF.IO/4PQXT
- Leslie, W. D., & Schousboe, J. T. (2011). A review of osteoporosis diagnosis and treatment options in new and recently updated guidelines on case finding around the world. Current Osteoporosis Reports, 9(3), 129−140. https://doi.org/10.1007/s11914-011-0060-5
- Leventhal, H., Benyamini, Y., Brownlee, S., Diefenbach, M., Leventhal, E. A., Patrick-Miller, L., & Robitaille, C. (1997). Illness representations: Theoretical foundations. Dans K. J. Petrie & J. A. Weinman (Éds.), Perceptions of health and illness: Current research and applications (p. 19–45). Harwood Academic Publishers.
- Leventhal, H., Meyer, D., & Nerenz, D. (1980). The common sense representation of illness danger. Contributions to Medical Psychology, 2, 7−30.
- Løchting, I., Fjerstad, E., & Garratt, A. M. (2013). Illness perceptions in patients receiving rheumatology rehabilitation: Association with health and outcomes at 12 months. BMC Musculoskeletal Disorders, 14(1), 1−7. https://doi.org/10.1186/1471-2474-14-28
- Margat, A., Gagnayre, R., Lombrail, P., de Andrade, V., & Azogui-Levy, S. (2017). Health literacy and patient education interventions: A review. Santé publique, 29(6), 811−820. https://doi.org/10.3917/spub.176.0811
- Mazor, K. M., Velten, S., Andrade, S. E., & Yood, R. A. (2010). Older women’s views about prescription osteoporosis medication: A cross-sectional, qualitative study. Drugs & Aging, 27(12), 999−1008. https://doi.org/10.2165/11584790-000000000-00000
- Miles, M. B., & Huberman, A. M. (2003). Analyse des données qualitatives (2e éd.). De Boeck Supérieur.
- Mitzel, L. D., & Vanable, P. A. (2020). Necessity and concerns beliefs and HIV medication adherence: A systematic review. Journal of Behavioral Medicine, 43(1), 1−15. https://doi.org/10.1007/s10865-019-00089-2
- Neuner, J. M., & Schapira, M. M. (2014). Patient perceptions of osteoporosis treatment thresholds. The Journal of Rheumatology, 41(3), 516−522. https://doi.org/10.3899/jrheum.130548
- Nie, B., Chapman, S. C., Chen, Z., Wang, X., & Wei, L. (2019). Utilization of the beliefs about medicine questionnaire and prediction of medication adherence in China: A systematic review and meta-analysis. Journal of Psychosomatic Research, 122, 54−68. https://doi.org/10.1016/j.jpsychores.2019.03.184
- Orimo, H., Sato, M., Kimura, S., Wada, K., Chen, X., Yoshida, S., & Crawford, B. (2017). Understanding the factors associated with initiation and adherence of osteoporosis medication in Japan: An analysis of patient perceptions. Osteoporosis and Sarcopenia, 3(4), 174−184. https://doi.org/10.1016/j.afos.2017.10.002
- Palacios, S., Agodoa, I., Bonnick, S., Van den Bergh, J. P., Ferreira, I., Ho, P. R., & Brown, J.P. (2015). A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: Effects on bone density and fracture. Menopause, 22(8), 806−813. https://doi.org/10.1097/GME.0000000000000419
- Paillé, P., & Mucchielli, A. (2008). L’analyse qualitative en sciences humaines et sociales. Armand Colin.
- Papaioannou, A., Kennedy, C. C., Dolovich, L., Lau, E., & Adachi, J. D. (2007). Patient adherence to osteoporosis medications. Drugs & Aging, 24(1), 37−55. https://doi.org/10.2165/00002512-200724010-00003
- Payer, J., Killinger, Z., Šulková, I., & Celec, P. (2008). Preferences of patients receiving bisphosphonates–how to influence the therapeutic adherence. Biomedicine & Pharmacotherapy, 62(2), 122−124. https://doi.org/10.1016/j.biopha.2007.07.005
- Reynolds, K., Muntner, P., Cheetham, T. C., Harrison, T. N., Morisky, D. E., Silverman, S., Gold, D. T., Vansomphone, S. S., Wei, R., & O’Malley, C. D. (2013). Primary non-adherence to bisphosphonates in an integrated healthcare setting. Osteoporosis International, 24(9), 2509−2517. https://doi.org/10.1007/s00198-013-2326-5
- Ringe, J. D., Farahmand, P., Faber, H., & Dorst, A. (2009). Sustained efficacy of risedronate in men with primary and secondary osteoporosis: Results of a 2-year study. Rheumatology International, 29(3), 311−315. https://doi.org/10.1007/s00296-008-0689
- Rosenstock, I. M. (1974). The health belief model and preventive health behavior. Health Education Monographs, 2(4), 354−386. https://doi.org/10.1177/109019817400200405
- Samalin, L. (2016). Attitudes et croyances vis-à-vis du traitement comme variables intermédiaires du comportement d'usage du médicament [Thèse de doctorat, Université d’Auvergne-Clermont-Ferrand]. HAL thèses. https://theses.hal.science/tel-01543415
- Sewerynek, E., Dąbrowska, K., Skowrońska-Jóźwiak, E., Zygmunt, A., & Lewiński, A. (2009). Compliance with alendronate 10 treatment in elderly women with postmenopausal osteoporosis. Endokrynologia Polska, 60(2), 76−81.
- Stilley, C. S., Sereika, S., Muldoon, M. F., Ryan, C. M., & Dunbar-Jacob, J. (2004). Psychological and cognitive function: Predictors of adherence with cholesterol lowering treatment. Annals of Behavioral Medicine, 27(2), 117−124. https://doi.org/10.1207/s15324796abm2702_6
- Stuurman-Bieze, A. G. G., Hiddink, E. G., Van Boven, J. F. M., & Vegter, S. (2014). Proactive pharmaceutical care interventions decrease patients’ nonadherence to osteoporosis medication. Osteoporosis International, 25(6), 1807−1812. https://doi.org/10.1007/s00198-014-2659-8
- Tamechika, S. Y., Sasaki, K., Hayami, Y., Ohmura, S. I., Maeda, S., Iwagaitsu, S., & Naniwa, T. (2018). Patient satisfaction and efficacy of switching from weekly bisphosphonates to monthly minodronate for treatment and prevention of glucocorticoid-induced osteoporosis in Japanese patients with systemic rheumatic diseases: A randomized, clinical trial. Archives of Osteoporosis, 13(67), 1−12. https://doi.org/10.1007/s11657-018-0451-7
- Tsamlag, L., Wang, H., Shen, Q., Shi, Y., Zhang, S., Chang, R., Lui, X., Shen, T., & Cai, Y. (2020). Applying the Information–Motivation–Behavioral Model to explore the influencing factors of self-management behavior among osteoporosis patients. BMC Public Health, 20(198), 1−8. https://doi.org/10.1186/s12889-020-8292-x
- Thompson, P., Cooper, C., & Carr, A. (2005). Factors influencing adherence to bisphosphonates for osteoporosis. Journal of Bone and Mineral Research, 20(9), S394−S394.
- West, L. M., Borg Theuma, R., & Cordina, M. (2020). The ‘Necessity–Concerns Framework’ as a means of understanding non-adherence by applying polynomial regression in three chronic conditions. Chronic Illness, 16(4), 253−265. https://doi.org/10.1177/1742395318799847
- Weycker, D., Macarios, D., Edelsberg, J., & Oster, G. (2006). Compliance with drug therapy for postmenopausal osteoporosis. Osteoporosis International, 17(11), 1645−1652. https://doi.org/10.1007/s00198-006-0179-x
- Wyke, S., Adamson, J., Dixon, D., & Hunt, K. (2013). Consultation and illness behaviour in response to symptoms: A comparison of models from different disciplinary frameworks and suggestions for future research directions. Social Science & Medicine, 86, 79−87. https://doi.org/10.1016/j.socscimed.2013.03.007